![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1384300
¼¼°è ¾ç¼ºÀÚ Ä¡·á ½Ã½ºÅÛ ½ÃÀå - ¼Â¾÷ À¯Çüº°, ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº° ¿¹Ãø(-2032³â)Proton Therapy Systems Market - By Set-up Type (Single Room, Multiple Room), By Indication (Breast Cancer, Lung Cancer, Prostate Cancer, Gastro-intestinal Cancer, Brain Cancer), By End-use (Hospitals, Proton Therapy Centers) - Global Forecast to 2032 |
¾ç¼ºÀÚ Ä¡·á ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â Ä¡·á °á°ú °³¼±À¸·Î À̾îÁö´Â ±â¼úÀÇ Áøº¸·Î 2023³âºÎÅÍ 2032³â±îÁö 10.5% ÀÌ»óÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿¹¸¦ µé¾î, Ææ½½ ºö ½ºÄ³´×°ú °µµ º¯Á¶ ¾ç¼ºÀÚ Ä¡·á´Â Ä¡·á Á¤È®µµ¸¦ ³ôÀ̰í Ä¡·á °¡´ÉÇÑ º´¸®ÇÐÀÇ ¹üÀ§¸¦ È®´ëÇÕ´Ï´Ù. 2023³â 10¿ù, Mevion Medical Systems´Â ¹Ì±¹°ú ij³ª´Ù¿¡¼ ¾Ï ¹æ»ç¼± Ä¡·á¿¡ »ç¿ëµÇ´Â ÄÄÆÑÆ®ÇÑ ¾ç¼ºÀÚ·á Ä¡·á ½Ã½ºÅÛÀÎ Mevion CapitalÀ» Ãâ½ÃÇß½À´Ï´Ù.
¶ÇÇÑ ¹æ»ç¼±¿¡ ÀÇÇÑ ÇÕº´ÁõÀÇ À§ÇèÀÌ ³·°í °Ç°ÇÑ Á¶Á÷¿¡ ´ëÇÑ ¼Õ»óÀÌ ÃÖ¼ÒȵDZ⠶§¹®¿¡ ¾ç¼ºÀÚ Ä¡·á´Â ¼Ò¾Æ¿Í ¼ºÀΠȯÀÚ¿¡°Ô ¼±È£µÇ´Â ¼±ÅÃÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀÌÀ¯·Î ¾ç¼ºÀÚ Ä¡·á ½Ã½ºÅÛÀÇ µµÀÔ°ú ¼ö¿ä°¡ ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾Ï ȯÀÚÀÇ È®´ë³ª Áö¿øÀûÀÎ »óȯ Á¤Ã¥Àº ½ÃÀå ¼ºÀåÀÇ ±Ëµµ¿¡ ´õ¿í ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.
¸ÖƼ·ë ¼³Ä¡ À¯ÇüÀº ´õ ¸¹Àº ȯÀÚ¸¦ È¿À²ÀûÀ¸·Î Ä¡·áÇϰí, ´ë±â ½Ã°£À» ´ÜÃàÇϰí, ´õ ³ªÀº °Ç° °ü¸®¸¦ Á¦°øÇÒ ¼ö Àֱ⠶§¹®¿¡ 2032³â±îÁö »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼³Àº ¿©·¯ Ä¡·á½ÇÀ» °®Ãß°í ÀÖÀ¸¸ç, ÀÇ·á ¼ºñ½º Á¦°ø¾÷ü´Â ´õ ¸¹Àº ȯÀÚ¸¦ ¼ö¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á½Ã¼³ÀÌ ¾ç¼ºÀÚ Ä¡·á ´É·ÂÀ» È®´ëÇϱâ À§ÇØ ÅõÀÚ¸¦ °è¼ÓÇÒ¼ö·Ï Á¦Ç° ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¾ç¼ºÀÚ Ä¡·á ¼¾ÅÍÀÇ ÃÖÁ¾ ¿ëµµ ºÎ¹®Àº 2032³â±îÁö °Å¾×ÀÇ ¼öÀÍÀ» ¿Ã¸± °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Àü¿ë ¼¾Åʹ ȯÀÚ¿¡°Ô Á¾ÇÕÀûÀÎ ¾ç¼ºÀÚ Ä¡·á ¼ºñ½º¸¦ Á¦°øÇϰí ÃÖ°í ǰÁúÀÇ Ä¡·á¸¦ º¸ÀåÇϱ⠶§¹®ÀÔ´Ï´Ù. ¾ç¼ºÀÚ Ä¡·á ¼¾ÅÍ´Â ¾Ï°úÀÇ ½Î¿ò¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ±× ¼ö´Â Áõ°¡ÇÏ´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. ¾ç¼ºÀÚ Ä¡·á ¼¾ÅÍ´Â ´Ù¾çÇÑ Ä¡·á ¿É¼ÇÀ» Á¦°øÇϸç Á¾Á¾ ÃÖ÷´Ü ±â¼úÀ» °®Ãß°í Àֱ⠶§¹®¿¡ ½ÃÀå È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾ç ¾ç¼ºÀÚ Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀº 2023³âºÎÅÍ 2032³â±îÁö °ÇÑ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â Áß±¹, ÀϺ», Çѱ¹ µîÀÇ ³ª¶ó¿¡¼ ¾Ï ÀÌȯÀ² Áõ°¡, ÇコÄɾî ÀÎÇÁ¶óÀÇ °³Ã´ÀÌ ÁøÇàµÇ°í ÀÖ´Â °Í, ÀÇ·á ÁöÃâÀÌ Áõ°¡Çϰí ÀÖ´Â °Í¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ¾Ï Ä¡·á ¿É¼ÇÀ» ´Ã¸®´Â µ¥ ÁßÁ¡À» µÐ APAC Áö¿ª¿¡¼´Â ¾ç¼ºÀÚ Ä¡·á ¼¾ÅÍ ¼³¸³ÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¼¾ÅÍ´Â ÃֽŠ¾ç¼ºÀÚ Ä¡·á ½Ã½ºÅÛÀ» °®Ãß°í ÀÖÀ¸¸ç, ÀÌ Áö¿ªÀÇ ÁֹεéÀÌ ¼±ÁøÀûÀÎ ¾Ï Ä¡·á¿¡ Á¢±ÙÇϱ⠽¬¿öÁö°í ÀÖ½À´Ï´Ù.
Proton therapy system market size is expected to record more than 10.5% CAGR from 2023 to 2032 due to the technological advancements that lead to improved results. For instance, pencil beam scanning and intensity-modulated proton therapy have enhanced treatment precision and expanded the range of treatable conditions. In October 2023, Mevion Medical Systems launched 'Mevion Capital' in US and Canada, a compact proton therapy system for use in radiation therapy of cancer.
Furthermore, the lower risk of radiation-induced complications and minimal damage to healthy tissues make proton therapy a preferred choice for both pediatric and adult patients. This has led to increased adoption and demand for proton therapy systems worldwide. The expanding pool of cancer patients and supportive reimbursement policies further influence the market growth trajectory.
The overall proton therapy systems market is divided based on set-up type, indication, end-use, and region.
The multiple room set-up type segment is predicted to witness substantial growth through 2032 due to their ability to treat more patients efficiently, reducing waiting times and providing a better healthcare experience. Such facilities are equipped with multiple treatment rooms and enable healthcare providers to cater to a larger patient population. As healthcare facilities continue to invest in expanding their proton therapy capabilities, the product demand will increase.
The proton therapy center end-use segment is anticipated to generate massive revenues by 2032 as these dedicated centers offer comprehensive proton therapy services to patients, ensuring the highest quality of care. Proton therapy centers are playing a crucial role in the fight against cancer, and their numbers are on the rise. They offer a range of treatment options and are often equipped with state-of-the-art technology, making them a key contributor to the market expansion.
Asia Pacific proton therapy systems market will record strong CAGR from 2023 to 2032 attributed to the growing prevalence of cancer, increasing healthcare infrastructure development, and rising medical expenditure in countries such as China, Japan, and South Korea. With a focus on enhancing cancer treatment options, the APAC region is witnessing a surge in the establishment of proton therapy centers. These centers are equipped with the latest proton therapy systems, facilitating access to advanced cancer treatments for the population in the region.